A statistical difference in the means of tau scores was observed between pre-AD and AD (p < 0.01), between PART with Braak NFT stage I/II and pre-AD/AD (p < 0.01), between PART with Braak NFT stage III/IV and AD (p < 0.01). The gene discussed is MAPT; the disease is Alzheimer disease.